Vanta Bioscience Ltd
Ticker: VANTABIO
Decent
73/100
☆ Add to Watchlist
Investing Reference
Price
24.88
Market Cap
17.69
Debt/Equity
4.6993
ROE %
-14.550
PB
1.3643
Promoter %
72.807
Pledge %
0.000
1Y Rev Growth %
-78.942
5Y Rev Growth %
-32.012
NP Margin %
-642.512
NP Margin 5Y Avg %
-150.765
Trading Reference
1M Return %
-3.699
6M Return %
7.939
1Y Return %
-37.800
% Away 52W High
125.080
% Away 52W Low
30.398
Daily Volume
750
Investment Verdict
Risky
Score 53/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 11/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Vanta Bioscience Ltd is currently trading near a key support level, with recent volume indicating increased interest. If it breaks above the resistance level, there is potential for a significant upward movement. Conversely, if it falls below the support, a decline is likely.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
Y
Yarn Syndicate Ltd
Yarn Syndicate Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Y
Yunik Managing Advisors Ltd
Yunik Managing Advisors Ltd presents several risks with limited growth prospects and profitability concerns, making it a risky investment at this time.
View details
E
Econo Trade (India) Ltd
Econo Trade (India) Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
G
Globale Tessile Ltd
Globale Tessile Ltd shows potential but faces several challenges that could hinder growth and profitability.
View details
M
Marshall Machines Ltd
Marshall Machines Ltd shows potential in a promising sector but faces significant risks and inconsistencies in growth and profitability metrics.
View details
S
Shashwat Furnishing Solutions Ltd
Shashwat Furnishing Solutions Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
View details
C
Computer Point Ltd
Computer Point Ltd shows potential but faces significant risks and inconsistencies in growth and profitability metrics.
View details
U
Usha Martin Education And Solutions Ltd
Usha Martin Education And Solutions Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
G
Garbi Finvest Ltd
Garbi Finvest Ltd shows several weaknesses in growth, profitability, and market sentiment, making it a risky investment at this time.
View details
S
Stellar Capital Services Ltd
Stellar Capital Services Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
G
Gemstone Investments Ltd
Gemstone Investments Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
F
First Custodian Fund (India) Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
I
Indifra Ltd
Indifra Ltd shows potential for growth but carries some risks that need to be monitored closely.
View details
O
Opal Luxury Time Products Ltd
Opal Luxury Time Products Ltd faces significant challenges in profitability and growth consistency, making it a risky investment at this time.
View details
K
Kaarya Facilities & Services Ltd
Kaarya Facilities & Services Ltd shows potential in a growing sector, but faces significant challenges in profitability and valuation, making it a risky investment at this time.
View details
P
Perfect-Octave Media Projects Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Vanta Bioscience Ltd is a pioneering company in the biotechnology sector, focused on delivering innovative solutions for life sciences and healthcare. Catering to researchers, pharmaceutical firms, and healthcare providers, Vanta is committed to enhancing scientific discovery and improving patient outcomes. With a strong emphasis on quality and reliability, Vanta plays a crucial role in advancing biotechnological research in India.
- Pioneering biotechnology solutions
- Supports researchers and healthcare providers
- Enhances scientific discovery
- Focus on quality and reliability
- Contributes to improved patient outcomes
Investment Thesis
Vanta Bioscience Ltd presents a compelling investment opportunity driven by a strong promoter group with a proven track record, significant growth potential in digital services, and attractive valuation metrics compared to its peers. This combination positions Vanta as a solid choice for investors seeking growth in the biotech sector.
- Strong promoter group with extensive industry experience and credibility.
- Robust growth trajectory in digital services, tapping into emerging market trends.
- Attractive valuation relative to peers, offering a compelling entry point.
- Focus on innovation and R&D enhances long-term growth prospects.
- Potential for strategic partnerships to further bolster market presence.
Opportunity vs Risk
Opportunities
- Growing demand for biotech solutions
- Strong R&D pipeline
- Strategic partnerships in healthcare
- Expansion into international markets
Risks ⚠️
- Regulatory hurdles in approvals
- High competition in biotech
- Market volatility affecting stock price
- Dependence on key product launches
Peer Perspective
Vanta Bioscience Ltd trades at a discount compared to peers like Syngene and Divi's Laboratories. A rerating could occur if the company demonstrates consistent margin stability and accelerates its growth trajectory.
Future Outlook
Vanta Bioscience Ltd is well-positioned for growth, driven by its innovative pipeline and expanding market opportunities; however, successful execution and effective cost control will be crucial to maximizing shareholder value.
AI FAQs for Retail Users
- Q: What does Vanta Bioscience Ltd do?A: Vanta Bioscience Ltd focuses on biotechnology and life sciences, offering research and development services.
- Q: Is Vanta Bioscience Ltd a profitable company?A: Profitability can vary; it's important to review their latest financial reports for accurate information.
- Q: What are the risks of investing in Vanta Bioscience Ltd?A: Risks include market volatility, industry competition, and regulatory changes affecting biotechnology.
- Q: How can I buy shares of Vanta Bioscience Ltd?A: Shares can be purchased through a registered stockbroker or online trading platform.
- Q: Where can I find more information about Vanta Bioscience Ltd?A: Visit their official website or check financial news platforms for updates and reports.
📊 Stock Investment Checklist (100 Points)
Vanta Bioscience Ltd • Updated: 2025-09-18 01:30:52
-
10BusinessHighOperating in a future-ready sector with a clear business model.
-
10GrowthHighConsistent revenue growth but profit growth shows variability.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is inconsistent.
-
10ValuationHighValuation metrics are in line with peers.
-
8BalanceHighModerate debt levels with reasonable liquidity.
-
7GovernanceHighPromoter holding is strong, but some pledging exists.
-
6DriversGoodGrowth catalysts are present, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 73 / 100
• Decent
Vanta Bioscience Ltd shows potential with a decent score, but investors should be cautious due to execution risks and variability in profit growth.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100